Activating TFEB and ADAM17 using CRISPRa to treat neurodegenerative diseases
Enhancing Therapeutic Genes to cure Neurodegenerative diseases Alzheimer’s and Parkinson’s are the leading cause of neurodegenerative disease around the world. Research so far has only progressed towards reducing the symptoms linked with these diseases with no cure having been developed. Alzheimer’s and Parkinson’s share similar pathology in the way that they develop and form protein clumps which
